Zobrazeno 1 - 10
of 738
pro vyhledávání: '"Biologic drugs"'
Autor:
Bertin L, Crepaldi M, Zanconato M, Lorenzon G, Maniero D, De Barba C, Bonazzi E, Facchin S, Scarpa M, Ruffolo C, Angriman I, Buda A, Zingone F, Savarino EV, Barberio B
Publikováno v:
Clinical and Experimental Gastroenterology, Vol Volume 17, Pp 261-315 (2024)
Luisa Bertin,1 Martina Crepaldi,1 Miriana Zanconato,1 Greta Lorenzon,1 Daria Maniero,1 Caterina De Barba,1 Erica Bonazzi,1 Sonia Facchin,1 Marco Scarpa,2 Cesare Ruffolo,2 Imerio Angriman,2 Andrea Buda,3 Fabiana Zingone,1 Edoardo Vincenzo Savarino,1 B
Externí odkaz:
https://doaj.org/article/61ca8e7ece82421281b8e64755e3d3e9
Autor:
Karam R. Motawea, Yomna A. Abdelghafar, Yossef H. AbdelQadir, Merna M. Aboelenein, Nancy Ibrahim, Mohamed M. Belal, Rowan H. Elhalag, Lina T. Khairy, Agyad Bakkour, Ali H. H. Muwaili, Fatima A. A. Abdelmajid, Mhd K. Albuni, Elias Battikh, Bisher Sawaf, Eman M. S. Ahmed, Dhuha H. H. Muwaili, Sarya Swed
Publikováno v:
Health Science Reports, Vol 7, Iss 5, Pp n/a-n/a (2024)
Abstract Background Etrolizumab is a promising drug for treating moderate to severe ulcerative colitis. Aim The aim of this study was to assess the efficacy and safety of etrolizumab for induction and maintenance of remission in moderate to severe ul
Externí odkaz:
https://doaj.org/article/9938b1ce661f4706ab260055ce4e245d
Autor:
Giampiero Girolomoni, Laura Savage, Paolo Gisondi, Åke Svensson, Emmanuel Mahé, Matthias Augustin, Luis Puig
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 10, Pp 2171-2185 (2023)
Abstract Psoriasis is a chronic, immune-mediated inflammatory disease with a worldwide prevalence ranging between 0.51 and 11.43%. It results in a large clinical and social burden, with patients frequently suffering from reduced quality of life, psyc
Externí odkaz:
https://doaj.org/article/b18142dd5e224630bc28e18b5cd73f68
Autor:
Cacciapuoti S, Potestio L, Guerrasio G, Fabbrocini G, Scalvenzi M, Ruggiero A, Caiazzo G, Megna M
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 16, Pp 2637-2644 (2023)
Sara Cacciapuoti,* Luca Potestio,* Gianluca Guerrasio, Gabriella Fabbrocini ,† Massimiliano Scalvenzi, Angelo Ruggiero,* Giuseppina Caiazzo,* Matteo Megna* Section of Dermatology - Department of Clinical Medicine and Surgery, Un
Externí odkaz:
https://doaj.org/article/7a6b415202844f2bbe913645464a45f8
Autor:
Orazio Palmieri, Fabrizio Bossa, Stefano Castellana, Tiziana Latiano, Sonia Carparelli, Giuseppina Martino, Manuel Mangoni, Giuseppe Corritore, Marianna Nardella, Maria Guerra, Giuseppe Biscaglia, Francesco Perri, Tommaso Mazza, Anna Latiano
Publikováno v:
Microorganisms, Vol 12, Iss 7, p 1260 (2024)
Growing evidence suggests that alterations in the gut microbiome impact the development of inflammatory bowel diseases (IBDs), including Crohn’s disease (CD) and ulcerative colitis (UC). Although IBD often requires the use of immunosuppressant drug
Externí odkaz:
https://doaj.org/article/812d1e99320741109964fb6d83b75e25
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 16, Pp 2045-2059 (2023)
Luca Potestio,1 Elisa Camela,2 Sara Cacciapuoti,1 Luigi Fornaro,1 Angelo Ruggiero,1 Fabrizio Martora,1 Teresa Battista,1 Matteo Megna1 1Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Ita
Externí odkaz:
https://doaj.org/article/2ae5301db5bd4448aa22d5b81c3f1c70
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 16, Pp 1677-1690 (2023)
Matteo Megna,1 Elisa Camela,2 Angelo Ruggiero,1 Teresa Battista,1 Fabrizio Martora,1 Sara Cacciapuoti,1 Luca Potestio1 1Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy; 2Dermatology
Externí odkaz:
https://doaj.org/article/e29de139920544e8be11ea111679a5ff
Autor:
Stefano Dastoli, Maria Passante, Francesco Loconsole, Edoardo Mortato, Anna Balato, Vincenzo Piccolo, Claudio Guarneri, Laura Macca, Eugenio Provenzano, Giancarlo Valenti, Domenico D’Amico, Giuseppe Micali, Maria Letizia Musumeci, Giovanni Palazzo, Caterina Foti, Paolo Romita, Gabriella Fabbrocini, Matteo Megna, Ilaria Sammarra, Luigi Bennardo, Cataldo Patruno
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Background Long-term real-life data on secukinumab use in psoriasis are limited. Objectives Determine the long-term effectiveness of secukinumab in moderate-to-severe psoriasis in real-life. Methods Multicenter retrospective study analyzing data from
Externí odkaz:
https://doaj.org/article/4fa564bfcdbe423d8500634beff35987
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 6, Iss 5, Pp 198-200 (2023)
Externí odkaz:
https://doaj.org/article/9165c46624c141aa98c04a3b3e260683
Autor:
Roman A. Ivanov, Nikolay N. Murashkin
Publikováno v:
Вопросы современной педиатрии, Vol 21, Iss 5, Pp 419-429 (2022)
Background. Psoriasis is a chronic immune-mediated disease with multifactorial nature. It often requires administration of genetically engineered biologic drugs. They have a number of features and risks that depend on various factors. The results of
Externí odkaz:
https://doaj.org/article/b1389e02db664b6db5923410d67073c9